Invest in pharma for safety but be wary of IT names now: Pashupati Advani

economictimes.indiatimes.com:

Pashupati Advani of Global Foray says pharma is back in fashion again. With the pricing pressure in the US to lower drug prices, it is going to be the day of the generics again and India will be back in that space and we are seeing it already.

Coming to IT, Advani says: “I am not as wild about IT names. However, with the dollar getting stronger against the rupee, they are going to make money without doing anything. I actually see a big move with ChatGPT, AI, stuff like that which is actually going to hurt our IT names unless they are able to move fast.”
Let’s talk about FMCG stocks because Dabur on Thursday had a fall that came in from that front as well. Nothing in terms of a participation is coming in for the FMCG pack, even when we are seeing a bit of a run up. What should one watch out for from the FMCG sector?
Pashupati Advani: The FMCG sector has chugged along and has been the first place to put money because we need the FMCG to go. But it looks like there is some pushback from the organised sector. I do not know whether it is actually getting replaced by the unorganised sector or if there are new players, because we are seeing downtrends in Lever, Dabur and other big names.

Unlock Leadership Excellence with a Range of CXO Courses

I do not understand what is going on in that sector. Maybe there are some hidden numbers